Anxiety & Cannabis

Anxiety After Quitting Weed: When to Consider Medication

By RethinkTHC Research Team|15 min read|February 24, 2026

Anxiety & Cannabis

50-60%

Research in JAMA Psychiatry found that 50 to 60 percent of heavy cannabis users have a co-occurring anxiety disorder, meaning post-quit anxiety may be an unmasked condition that benefits from medication.

Blanco et al., JAMA Psychiatry, 2016

Blanco et al., JAMA Psychiatry, 2016

Infographic showing 50 to 60 percent of heavy cannabis users have co-occurring anxiety disorder unmasked after quittingView as image

You quit weed. The first few weeks were rough, but you expected that. What you did not expect is that your anxiety would still be this bad two or three months later. Maybe worse. You are lying awake at night, your stomach is in knots before work, and the same thought keeps circling. You are wondering whether you need anxiety medication after quitting weed.

That question is not a sign of weakness. It is a sign that you are paying attention. And you are not the only person asking it. A significant number of people who quit cannabis discover that the anxiety they were self-medicating was never just about weed. The weed was a lid on something that needed real treatment.

This article is for people who have already quit and are now wondering whether medication might help. If you are on the other side of this situation (already taking anxiety medication and considering quitting weed), that is a different conversation with different considerations.

Key Takeaways

  • Cannabis withdrawal anxiety usually peaks in the first 1-2 weeks and clears up within 4-6 weeks, but if serious anxiety is still there after 8 weeks it may point to an underlying anxiety disorder that existed before — or was hidden by — cannabis use
  • SSRIs (like sertraline and escitalopram) and buspirone are first-line options for post-cannabis anxiety because they are non-addictive and help repair the serotonin disruption that long-term THC use leaves behind
  • Benzodiazepines (Xanax, Klonopin) carry real dependency risk — especially for someone who just quit one substance — so most doctors will avoid prescribing them here
  • About 50-60% of people who use cannabis heavily have a co-occurring anxiety disorder, which means the anxiety you feel after quitting may not be just withdrawal
  • Medication is not the only path forward, but it is a legitimate one — there is no moral failure in needing pharmacological support after years of self-medicating
  • Blanco et al. (2016, JAMA Psychiatry) found that roughly 50-60% of people with cannabis use disorder also meet criteria for an independent anxiety disorder, so the anxiety after quitting may be an unmasked pre-existing condition rather than just withdrawal

The 8-Week Benchmark: Withdrawal vs. Something Deeper

Anxiety & Cannabis

Post-Cannabis Anxiety: Medication Decision Guide

Withdrawal vs. underlying disorder — the 8-week benchmark:
Weeks 1–4
Withdrawal anxiety — expected, usually resolvingNon-pharmacological tools (breathing, exercise, therapy)
Weeks 4–8
Improving but still present — monitorContinue tools; consider therapy if not already started
8+ weeks
Significant anxiety persists → likely pre-existing disorderTalk to doctor about medication — this is the benchmark
SSRIsAddiction risk: None
Examples:

Sertraline (Zoloft), Escitalopram (Lexapro)

Onset:

4–6 weeks

Fit:

First-line for persistent post-cannabis anxiety

BuspironeAddiction risk: None
Examples:

Buspirone (BuSpar)

Onset:

2–4 weeks

Fit:

Under-the-radar option; targets serotonin without SSRI side effects

BenzosAddiction risk: High
Examples:

Alprazolam (Xanax), Clonazepam (Klonopin)

Onset:

Minutes

Fit:

Usually NOT recommended — dependency risk too high after quitting one substance

Source: Blanco et al. JAMA Psychiatry (2016); Budney et al. (2003)Post-Cannabis Anxiety: Medication Decision Guide

Not all post-quit anxiety is the same. The first question to answer is whether what you are feeling is still withdrawal or something more persistent.

Weed withdrawal anxiety follows a well-documented pattern. Budney and colleagues, publishing in Journal of Abnormal Psychology, established that cannabis withdrawal symptoms begin within 1-3 days, peak around days 2-6, and gradually decline over 2-4 weeks.[1] Most people experience meaningful improvement by week 4-6.

But here is the critical distinction. If your anxiety is still significant at the 8-week mark, withdrawal alone probably is not the full explanation. At that point, your endocannabinoid system has had enough time to begin stabilizing. The acute neurochemical rebound is over. What remains is more likely your baseline anxiety level, the one that was always there underneath the cannabis.

Blanco and colleagues, in a large-scale epidemiological study published in JAMA Psychiatry, found that approximately 50-60% of people with cannabis use disorder also meet criteria for an independent anxiety disorder.[2] "Independent" is the key word. It means the anxiety exists on its own, not just as a withdrawal symptom.

There is also a third possibility. Long-term heavy cannabis use can cause lasting changes to the endocannabinoid system and to stress-response circuitry. A 2012 review by Crippa and colleagues in Neurotherapeutics showed that chronic THC exposure downregulates CB1 receptors in regions tied to anxiety regulation. Some of these changes take months to fully reverse. So even if you did not have an anxiety disorder before, your brain may now need support getting back to a functional baseline.

The 8-week mark is not a hard cutoff. It is a reasonable checkpoint. If anxiety is still significantly impacting your sleep, work, relationships, or daily functioning at that point, a conversation with a doctor is worth having.

What to Actually Tell Your Doctor

This is where many people get stuck. You might be worried about judgment, about having cannabis use on your medical record, or about being told you brought this on yourself. Those fears are understandable and, in most cases, unfounded.

Here is what your doctor needs to know:

How long and how much you used cannabis. Daily use for five years is different from weekend use for six months. The duration and intensity of use helps your doctor assess how much neuroadaptation occurred.

When you quit and what your anxiety timeline looks like. Was anxiety bad the first week and then got better, or has it been steady or worsening since you stopped? This timeline is the single most useful piece of diagnostic information.

Whether you had anxiety before you started using cannabis. Think back. Were you an anxious kid? Did you have anxiety symptoms before your first joint? Many people started using cannabis precisely because it helped with pre-existing anxiety. If so, that is critical information.

What you have already tried. Exercise, therapy, breathing techniques, sleep hygiene. If you have been doing the non-pharmacological work and still struggling, that context matters. It tells your doctor this is not a situation where lifestyle changes alone are likely to resolve things.

You do not need to be apologetic. You do not need to minimize your cannabis history. A good clinician will treat this information as diagnostically relevant, not morally relevant.

SSRI and SNRI Medications: The First-Line Option

If your doctor determines that medication is appropriate, the most likely starting point is an SSRI (selective serotonin reuptake inhibitor) or an SNRI (serotonin-norepinephrine reuptake inhibitor). These are medications like sertraline (Zoloft), escitalopram (Lexapro), or venlafaxine (Effexor).

Here is why they make sense for post-cannabis anxiety specifically. Long-term THC exposure disrupts serotonin signaling. Bambico and colleagues, in a 2010 study published in Journal of Neuroscience, demonstrated that chronic cannabinoid exposure reduced serotonin firing rates in the dorsal raphe nucleus, which is the brain's primary serotonin production center. When you quit cannabis, this disrupted serotonin system is part of why your anxiety feels so raw.

SSRIs work by increasing the amount of serotonin available in the gaps between neurons. They do not create serotonin. They keep what you have circulating longer. For someone whose serotonin signaling has been suppressed by years of cannabis use, this targeted support can be especially effective.

The timeline matters. SSRIs take 4-6 weeks to reach full therapeutic effect. The first 1-2 weeks can actually increase anxiety slightly before things improve. This is normal and not a sign the medication is making things worse. It is a temporary adjustment as your serotonin system recalibrates.

SSRIs are not addictive. You can discontinue them (gradually, with medical guidance) without the kind of withdrawal you experienced with cannabis. This is a common fear, and it is worth addressing directly: taking an SSRI does not mean trading one dependency for another.

Buspirone: The Under-the-Radar Option

Buspirone (brand name Buspar) is an anti-anxiety medication that does not get as much attention as SSRIs but deserves a closer look for post-cannabis anxiety.

Buspirone works on serotonin receptors (specifically the 5-HT1A receptor) and has anxiolytic properties without sedation, without dependency risk, and without the cognitive dulling that some people experience on SSRIs. Loane and Politis, in a 2012 review published in Therapeutic Advances in Psychopharmacology, highlighted buspirone's favorable side-effect profile compared to both SSRIs and benzodiazepines.

For someone coming off cannabis, buspirone has a practical advantage: it does not interact with the endocannabinoid system in ways that complicate recovery. It targets anxiety through a different pathway. And unlike benzodiazepines, it carries no abuse potential, which makes it a safer choice for someone who has already recognized a pattern of using substances to manage anxiety.

Like SSRIs, buspirone takes 2-4 weeks to reach full effect. It is not a quick fix. But for generalized anxiety that has outlasted the withdrawal window, it can be genuinely helpful.

Why Benzodiazepines Are Usually Not the Answer

If you are looking for fast relief, you might be hoping for a benzodiazepine like alprazolam (Xanax), clonazepam (Klonopin), or lorazepam (Ativan). These medications work almost immediately, reducing anxiety within 30-60 minutes.

The problem is straightforward. Benzodiazepines work on the GABA system, producing effects that are pharmacologically similar to the calming effects cannabis provided. They create tolerance quickly, meaning you need more over time for the same effect. They produce physical dependence, and benzodiazepine withdrawal is medically serious, far more dangerous than cannabis withdrawal.

For someone who just stopped self-medicating anxiety with one substance, starting another fast-acting, dependency-forming substance is a risky path. Most prescribers who understand this context will not prescribe benzodiazepines as a first-line treatment. If they do, it should be short-term (days to weeks, not months) and paired with a longer-term strategy like an SSRI or therapy.

This is not a moral judgment. Benzodiazepines are legitimate medications with real clinical uses. But for anxiety that emerged or worsened after quitting weed, the risk-benefit calculation usually does not favor them.

Medication Myths That Keep People Stuck

Several common fears prevent people from even having the medication conversation.

"It will change my personality." SSRIs and buspirone do not change who you are. They reduce the volume on your anxiety response. People who respond well to these medications typically report feeling more like themselves, not less. The anxiety was the distortion, not the medication.

"I will be on it forever." Many people take SSRIs for 6-12 months and then taper off successfully. Medication can serve as a bridge while your brain heals from long-term cannabis use and while you build coping skills through therapy and other approaches. It does not have to be permanent.

"I should be able to handle this without pills." You used cannabis for years to manage anxiety. That was also a chemical intervention, just an unregulated one with significant side effects. While cannabis does have some proven medical benefits, self-medicating anxiety with uncontrolled doses is not one of them. Choosing a studied, dosed, monitored medication instead is not a step backward. It is a more precise version of what you were already doing.

"It means something is really wrong with me." Anxiety disorders are the most common mental health conditions worldwide, affecting roughly 301 million people globally according to the World Health Organization. Needing treatment for anxiety is as medically routine as needing treatment for high blood pressure. The stigma is not proportional to the reality.

Medication Is Not the Only Path (But It Is a Valid One)

Medication works best when combined with other approaches. Cognitive behavioral therapy (CBT) has strong evidence for anxiety disorders and addresses the thinking patterns that maintain anxiety long after the neurochemistry stabilizes. Regular exercise produces measurable changes in GABA and serotonin. Consistent sleep patterns support the circadian rhythms that chronic cannabis use disrupted. The complete withdrawal recovery guide covers many of these strategies in detail.

The question is not medication or lifestyle changes. It is whether you need medication in addition to the lifestyle changes you are already making. If you have been exercising, sleeping well, reducing caffeine, practicing breathing techniques, and still struggling at the 8-week mark, medication is worth exploring.

When to Seek Professional Help

If your anxiety is interfering with your ability to work, maintain relationships, sleep, or function in daily life, and it has persisted beyond the typical withdrawal window of 4-6 weeks, talk to a healthcare provider. If you are experiencing panic attacks, persistent insomnia, or thoughts of self-harm, seek help immediately.

You can reach the SAMHSA National Helpline at 1-800-662-4357 for free, confidential, 24/7 referrals to local treatment facilities, support groups, and community-based organizations. Your primary care doctor can also evaluate you for anxiety and prescribe medication. You do not need to see a psychiatrist first, though a referral to one may be appropriate depending on your situation.

You quit cannabis because you wanted a clearer, better life. If anxiety is standing between you and that life, treating it is not a contradiction of your recovery. It is the next step in it. The goal was never to white-knuckle your way through suffering. The goal was to stop relying on an uncontrolled substance and start making informed decisions about your mental health. Considering medication, with professional guidance, is exactly that kind of informed decision.

The Bottom Line

Anxiety medication after quitting weed becomes a consideration when symptoms persist beyond the 8-week benchmark, indicating the anxiety may be an underlying disorder rather than withdrawal alone. Budney et al. (2003, Journal of Abnormal Psychology) established that cannabis withdrawal symptoms peak around days 2-6 and decline over 2-4 weeks. Blanco et al. (2016, JAMA Psychiatry) found 50-60% of people with cannabis use disorder meet criteria for an independent anxiety disorder. Three medication categories: SSRIs/SNRIs (sertraline, escitalopram, venlafaxine) are first-line because they address the serotonin disruption Bambico et al. (2010, Journal of Neuroscience) documented from chronic cannabinoid exposure — takes 4-6 weeks for full effect, non-addictive, does not interfere with endocannabinoid recovery; buspirone targets 5-HT1A receptors without sedation, dependency risk, or cognitive dulling, favorable profile per Loane and Politis (2012, Therapeutic Advances in Psychopharmacology); benzodiazepines are generally avoided due to GABA-system dependency risk that mirrors the pattern of cannabis self-medication. Doctor communication framework: use duration/amount, anxiety timeline since quitting, pre-cannabis anxiety history, and non-pharmacological strategies already attempted. Medication myths addressed: SSRIs do not change personality, most courses are 6-12 months not permanent, choosing precision pharmacology over self-medication is not weakness. Medication works best combined with CBT, exercise, and sleep hygiene.

Frequently Asked Questions

Sources & References

  1. 1RTHC-00134·Budney, Alan J. et al. (2003). When Heavy Users Quit Cannabis, Symptoms Show Up Fast and Ease Within Two Weeks.” Journal of Abnormal Psychology.Study breakdown →PubMed →
  2. 2RTHC-01106·Blanco, Carlos et al. (2016). Large US Study Found Cannabis Linked to Substance Use Disorders but Not Mood or Anxiety Disorders.” JAMA psychiatry.Study breakdown →PubMed →

Research Behind This Article

Showing the 8 most relevant studies from our research database.

Strong EvidenceMeta-Analysis

Regular cannabinoid use and inflammatory biomarkers: Systematic review and hierarchical meta-analysis.

Murri, Martino Belvederi · 2026

Cannabis use was associated with higher anti-inflammatory biomarkers (SMD = 0.298, PD = 99%) and pro-inflammatory biomarkers (SMD = 0.166, PD = 100%).

Strong EvidenceMeta-Analysis

The prevalence of cannabidiol (CBD) use in North America and Europe: A meta-analysis.

Weidberg, Sara · 2026

CBD use was significantly more prevalent in North America than Europe across all time periods.

Strong EvidenceMeta-Analysis

The Pleiotropic Influence of Cannabidiol and Tetrahydrocannabinol on Inflammatory Biomarkers: A Systematic Review and Meta-Analytical Synthesis.

Candeloro, Bruno Moreira · 2025

Pooled estimates showed trivial and imprecise effects: IL-6 (SMD -0.17, p=0.41), IL-8 (SMD -0.30, p=0.06), IL-10 (SMD -0.10, p=0.79), and TNF-alpha (SMD -0.09, p=0.62).

Strong EvidenceMeta-Analysis

Cannabinoids as a Potential Alternative to Opioids in the Management of Various Pain Subtypes: Benefits, Limitations, and Risks.

Chou, Roger · 2025

THC:CBD oral spray: small pain decrease (MD -0.54/10); high THC: small decrease (MD -0.78/10); CBD alone: no benefit (moderate SOE); THC products caused large dizziness increase (RR 3.57) and sedation increase (RR 5.04)..

Strong EvidenceMeta-Analysis

Cannabis Use Disorder Associated With Increased Risk of Postoperative Complications After Hip or Knee Arthroplasties: A Meta-analysis of Observational Studies.

Ding, Cheng · 2024

Across 10 studies with 17,981,628 participants, CUD was associated with significantly higher odds of medical complications (OR 1.33), implant-related complications (OR 1.75), cardiac complications (OR 1.95), stroke (OR 2.06), infections (OR 1.68), periprosthetic fracture (OR 1.42), mechanical loosening (OR 1.54), and dislocation (OR 1.88).

Strong EvidenceMeta-Analysis

Medical cannabinoids: a pharmacology-based systematic review and meta-analysis for all relevant medical indications.

Bilbao, Ainhoa · 2022

CBD showed high-grade evidence for epilepsy (SMD -0.5) and moderate-grade for Parkinsonism (SMD -0.41).

Strong EvidenceMeta-Analysis

Use of cannabidiol in the treatment of epilepsy: Lennox-Gastaut syndrome, Dravet syndrome, and tuberous sclerosis complex.

Silvinato, Antônio · 2022

CBD compared to placebo reduced seizure frequency by 33%, increased 50% seizure reduction by 20%, increased seizure freedom by 3%, and improved caregiver-assessed clinical impression by 21% in patients with refractory epilepsy..

Strong EvidenceMeta-Analysis

Cannabidiol in conjunction with clobazam: analysis of four randomized controlled trials.

Gunning, Boudewijn · 2021

CBD reduced primary seizure frequency versus placebo in LGS (treatment ratio 0.70) and Dravet syndrome (0.71) in the overall population.